CHS Inc (CHSCL) locks in receivables, repo funding to 2027

(Moderate)

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

CHS Inc. (CHSCL) disclosed that it amended key financing arrangements related to its receivables and loan financing. The company, through its indirect subsidiary Cofina Funding, LLC, entered into Omnibus Amendment No. 16 to its Amended and Restated Receivables Purchase Agreement and related Sale and Contribution Agreement. This amendment extends the term of CHS Inc.’s receivables and loans securitization facility to August 25, 2027, unless earlier terminated under the agreement, implements pricing revisions, and removes the credit spread adjustment, along with other administrative changes.

Separately, CHS Inc. entered into Omnibus Amendment No. 4 with Coöperatieve Rabobank U.A., New York Branch, relating to the Master Framework Agreement that governs the company’s repurchase financing facility. This amendment also extends the scheduled term of the repurchase financing facility to August 25, 2027 and includes administrative updates. CHS Inc. notes that these actions create direct financial obligations and off-balance sheet arrangements as described.

8-K Event Classification

2 items: 1.01, 2.03

2 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial

The company incurred a new significant debt or off-balance-sheet obligation.

Key Figures

Execution date of Omnibus Amendment No. 16: August 26, 2026 Execution date of Omnibus Amendment No. 4: August 26, 2026 Securitization facility term end date: August 25, 2027 +2 more

5 metrics

Execution date of Omnibus Amendment No. 16 August 26, 2026 Date CHS Inc. amended the Receivables Purchase Agreement and Sale and Contribution Agreement

Execution date of Omnibus Amendment No. 4 August 26, 2026 Date CHS Inc. amended the Master Framework Agreement for the repurchase facility

Securitization facility term end date August 25, 2027 Extended termination date for receivables and loans securitization facility, unless earlier terminated

Repurchase financing facility term end date August 25, 2027 Extended scheduled term under the Master Framework Agreement

Credit spread adjustment Removed Pricing revision under the amended Receivables Purchase Agreement

Key Terms

securitization facility, Receivables Purchase Agreement, Sale and Contribution Agreement, repurchase financing facility, +1 more

5 terms

securitization facility financial

"extend the term of the Company’s receivables and loans securitization facility"

A securitization facility is a financing arrangement that lets a company package loans or other receivables into tradable securities and sell them to investors, often with a backstop line or support to smooth timing and credit shortfalls. Think of it as a factory that bundles small loans into saleable blocks while a lender provides a safety net; for investors it matters because it affects the liquidity, credit profile and predictability of payments tied to those bundled assets.

Receivables Purchase Agreement financial

"that certain Amended and Restated Receivables Purchase Agreement, dated as of July 18, 2017"

A receivables purchase agreement is a contract where a company sells its outstanding invoices or amounts owed by customers to a buyer in exchange for immediate cash, usually at a discount. Investors care because it improves a company’s short‑term cash flow and can change reported assets, liabilities and risk exposure—like selling IOUs to get money now instead of waiting, which affects liquidity and the firm’s financial picture.

Sale and Contribution Agreement financial

"that certain Sale and Contribution Agreement, dated as of July 22, 2016"

repurchase financing facility financial

"the Company’s repurchase financing facility under the Framework Agreement"

Master Framework Agreement financial

"that certain Master Framework Agreement, dated July 11, 2023"

FAQ

What did CHSCL (CHS Inc.) change in its receivables securitization facility?

CHS Inc. entered Omnibus Amendment No. 16 to its Amended and Restated Receivables Purchase Agreement and related Sale and Contribution Agreement, extending the receivables and loans securitization facility’s term to August 25, 2027, revising pricing, and removing the credit spread adjustment, along with administrative changes.

How did CHSCL (CHS Inc.) amend its repurchase financing facility?

CHS Inc. entered Omnibus Amendment No. 4 with Coöperatieve Rabobank U.A., New York Branch, under the Master Framework Agreement. The amendment extends the scheduled term of the company’s repurchase financing facility to August 25, 2027 and implements certain administrative changes.

Which counterparties are involved in CHSCL’s securitization facility amendment?

The securitization amendment involves Cofina Funding, LLC as seller, CHS Inc. as servicer and performance guarantor for a section, CHS Capital, LLC as originator, various conduit and committed purchasers and purchaser agents, and MUFG Bank, Ltd. as administrative agent.

Who is the buyer under CHSCL’s repurchase financing facility?

Under the Master Framework Agreement for the repurchase financing facility, the buyer is Coöperatieve Rabobank U.A., New York Branch, a Dutch coöperative acting through its New York Branch, with CHS Inc. and CHS Capital, LLC as sellers.

Does the CHSCL 8-K describe new direct financial obligations or off-balance sheet arrangements?

Yes. CHS Inc. identifies the amended securitization and repurchase facilities as involving a direct financial obligation or an obligation under an off-balance sheet arrangement, by cross-referencing the financing amendments described in the same report.

When were the CHSCL financing amendments executed?

Both the Omnibus Amendment No. 16 for the receivables securitization facility and Omnibus Amendment No. 4 for the repurchase financing facility were executed on August 26, 2026, as disclosed by CHS Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

Available on EDGAR 08/26/2026 - 05:07 PM Accepted by SEC EDGAR 08/26/2026 - 05:06 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 26, 2026

CHS Inc.

(Exact Name of Registrant as Specified in its Charter)

Commission File Number: 001-36079

Minnesota

41-0251095

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification Number)

5500 Cenex Drive

Inver Grove Heights,

Minnesota

55077

(Address of principal executive offices, including zip code)

(651)

355-6000

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
8% Cumulative Redeemable Preferred Stock	CHSCP	The Nasdaq Stock Market LLC
Class B Cumulative Redeemable Preferred Stock, Series 1	CHSCO	The Nasdaq Stock Market LLC
Class B Reset Rate Cumulative Redeemable Preferred Stock, Series 2	CHSCN	The Nasdaq Stock Market LLC
Class B Reset Rate Cumulative Redeemable Preferred Stock, Series 3	CHSCM	The Nasdaq Stock Market LLC
Class B Cumulative Redeemable Preferred Stock, Series 4	CHSCL	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Securitization Facility Amendment

On August 26, 2026, CHS Inc. (the “Company”) entered into an Omnibus Amendment No. 16 (the “Receivables Purchase Agreement and Sale Agreement Amendment”), by and among Cofina Funding, LLC (“Cofina Funding”), an indirect subsidiary of the Company, as seller, the Company, as servicer, and, solely with respect to Section 7 of the Receivables Purchase Agreement and Sale Agreement Amendment, as the performance guarantor, CHS Capital, LLC (“CHS Capital”), as an originator, each of the conduit purchasers, committed purchasers and purchaser agents set forth on the signature pages thereto and MUFG Bank, Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as administrative agent (“MUFG”), to (i) that certain Amended and Restated Receivables Purchase Agreement, dated as of July 18, 2017, by and among Cofina Funding, the Company, the purchasers and the purchaser agents party thereto and MUFG (as previously amended, the “Receivables Purchase Agreement”) and (ii) that certain Sale and Contribution Agreement, dated as of July 22, 2016, by and among Cofina Funding, CHS Capital, and the Company (as previously amended, the “Sale and Contribution Agreement”). In addition to implementing certain administrative changes, the Receivables Purchase Agreement and Sale Agreement Amendment further amends and restates the Receivables Purchase Agreement to extend the term of the Company’s receivables and loans securitization facility provided under the Receivables Purchase Agreement to August 25, 2027, unless terminated earlier pursuant to the terms of the Receivables Purchase Agreement and implement pricing revisions (including removing the credit spread adjustment).

Repurchase Facility Amendment

On August 26, 2026, the Company entered into an Omnibus Amendment No. 4 (the “Omnibus Amendment No. 4”), by and among Coöperatieve Rabobank U.A., New York Branch, a Dutch coöperatieve acting through its New York Branch (“Rabobank”), as buyer, the Company and CHS Capital, LLC, a Minnesota limited liability company (“CHS Capital”), as sellers, the Company, as agent for the sellers and solely for purposes of Section 5.3 of the Omnibus Amendment No. 4, as guarantor, to that certain Master Framework Agreement, dated July 11, 2023, by and among Rabobank, the Company and CHS Capital (as previously amended, the “Framework Agreement”). In addition to implementing certain administrative changes, the Omnibus Amendment No. 4 extends the scheduled term of the Company’s repurchase financing facility under the Framework Agreement to August 25, 2027.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

Reference is made to the information set forth in Item 1.01 of this Current Report on Form 8-K, which is incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHS Inc.

Date: August 26, 2026

By:

/s/ Olivia Nelligan

Olivia Nelligan

Executive Vice President, Chief Financial Officer and Chief Strategy Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents